ATE209940T1 - Verbesserte transdermale vorrichtung mit verringerter delaminierung - Google Patents
Verbesserte transdermale vorrichtung mit verringerter delaminierungInfo
- Publication number
- ATE209940T1 ATE209940T1 AT95933122T AT95933122T ATE209940T1 AT E209940 T1 ATE209940 T1 AT E209940T1 AT 95933122 T AT95933122 T AT 95933122T AT 95933122 T AT95933122 T AT 95933122T AT E209940 T1 ATE209940 T1 AT E209940T1
- Authority
- AT
- Austria
- Prior art keywords
- transdermal device
- improved transdermal
- drug
- reduced delamination
- delamination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/315,043 US5635203A (en) | 1994-09-29 | 1994-09-29 | Transdermal device having decreased delamination |
PCT/US1995/011732 WO1996010429A2 (en) | 1994-09-29 | 1995-09-15 | Improved transdermal device having decreased delamination |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE209940T1 true ATE209940T1 (de) | 2001-12-15 |
Family
ID=23222625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95933122T ATE209940T1 (de) | 1994-09-29 | 1995-09-15 | Verbesserte transdermale vorrichtung mit verringerter delaminierung |
Country Status (9)
Country | Link |
---|---|
US (2) | US5635203A (de) |
EP (1) | EP0783341B1 (de) |
JP (2) | JPH11501527A (de) |
AT (1) | ATE209940T1 (de) |
DE (1) | DE69524436T2 (de) |
DK (1) | DK0783341T3 (de) |
ES (1) | ES2164780T3 (de) |
PT (1) | PT783341E (de) |
WO (1) | WO1996010429A2 (de) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882676A (en) * | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US6203817B1 (en) | 1997-02-19 | 2001-03-20 | Alza Corporation | Reduction of skin reactions caused by transdermal drug delivery |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US6660295B2 (en) | 1997-09-30 | 2003-12-09 | Alza Corporation | Transdermal drug delivery device package with improved drug stability |
US6699497B1 (en) * | 1998-07-24 | 2004-03-02 | Alza Corporation | Formulations for the transdermal administration of fenoldopam |
US6348210B1 (en) | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
BR9916214A (pt) * | 1998-12-18 | 2001-09-11 | Alza Corp | Dispositivos de distribuição de nicotina transdérmicos transparentes |
AU3536799A (en) * | 1999-04-26 | 2000-11-10 | Lead Chemical Co., Ltd. | Percutaneous preparations containing oxybutynin |
US6562368B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers |
US6586000B2 (en) * | 1999-12-16 | 2003-07-01 | Dermatrends, Inc. | Hydroxide-releasing agents as skin permeation enhancers |
US6582724B2 (en) | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
US6783294B2 (en) | 2000-02-14 | 2004-08-31 | Johnson & Johnson Consumer Companies, Inc. | Solid cleanser holder |
US6607739B1 (en) | 2000-02-14 | 2003-08-19 | Johnson & Johnson Consumer Companies, Inc. | Dispensing article |
US6436428B1 (en) | 2000-03-21 | 2002-08-20 | Enhance Pharmaceuticals, Inc. | Device and method for treating urinary incontinence in females |
US7029694B2 (en) * | 2000-04-26 | 2006-04-18 | Watson Laboratories, Inc. | Compositions and methods for transdermal oxybutynin therapy |
US7179483B2 (en) * | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
US20030124177A1 (en) * | 2000-04-26 | 2003-07-03 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
CN102327253A (zh) * | 2000-04-26 | 2012-01-25 | 沃特森药物公司 | 最小化与奥昔布宁疗法有关的副作用 |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
US20020198215A1 (en) * | 2000-10-23 | 2002-12-26 | Lino Tavares | Terazosin transdermal device and methods |
CN1250206C (zh) * | 2001-03-07 | 2006-04-12 | 久光制药株式会社 | 贴剂 |
DE10237057A1 (de) * | 2002-08-09 | 2004-03-25 | Grünenthal GmbH | Opioid-Rezeptor-Antagonisten in Pflasterformulierungen |
JP4354678B2 (ja) * | 2002-08-28 | 2009-10-28 | 久光製薬株式会社 | 貼付剤 |
US20040258742A1 (en) * | 2003-04-11 | 2004-12-23 | Van Osdol William Woodson | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
ES2258694T3 (es) * | 2003-11-11 | 2006-09-01 | Mattern, Udo | Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales. |
US20050234024A1 (en) * | 2004-04-14 | 2005-10-20 | Clarke David E | Materials and methods for the treatment of ulcerative colitis |
JP2005325165A (ja) * | 2004-05-12 | 2005-11-24 | Three M Innovative Properties Co | 100℃以下の温度で溶融塗布可能なヨウ素含有ホットメルト粘着剤および該粘着剤を用いた医療用粘着シート製品 |
US20070082039A1 (en) * | 2004-10-18 | 2007-04-12 | Jones Gerald S Jr | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids |
US8252320B2 (en) | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
WO2006047362A2 (en) | 2004-10-21 | 2006-05-04 | Durect Corporation | Transdermal delivery systems |
US20070087055A1 (en) * | 2005-10-14 | 2007-04-19 | David Jan | Directly compressible extended release alprazolam formulation |
US10010494B2 (en) | 2005-10-19 | 2018-07-03 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
US20070202156A1 (en) * | 2006-02-13 | 2007-08-30 | Aveva Drug Deliverty Systems | Adhesive preparation comprising sufentanil and methods of using same |
US8518926B2 (en) * | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
US20070259930A1 (en) * | 2006-04-10 | 2007-11-08 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
CA2651596C (en) * | 2006-05-08 | 2014-03-25 | Teikoku Seiyaku Co., Ltd. | Percutaneous absorption preparations of antidementia drugs |
CA2652251A1 (en) * | 2006-05-16 | 2007-11-29 | Knopp Neurosciences, Inc. | Compositions of r(+) and s(-) pramipexole and methods for using the same |
DK2068825T3 (da) | 2006-10-04 | 2011-05-16 | M & P Patent Ag | Kontrolleret frisætningstilførselssystem til nasal påføring af neurotransmittere |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
WO2008113056A2 (en) * | 2007-03-14 | 2008-09-18 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
US20110190356A1 (en) * | 2008-08-19 | 2011-08-04 | Knopp Neurosciences Inc. | Compositions and Methods of Using (R)- Pramipexole |
BRPI0917862A2 (pt) * | 2008-09-30 | 2015-11-24 | Teikoku Pharma Usa Inc | composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas |
EP2355806A2 (de) * | 2008-11-14 | 2011-08-17 | Profimed s.r.o. | Nichtwässrige kolloidale formulierung |
US8920392B2 (en) | 2009-05-05 | 2014-12-30 | Watson Laboratories, Inc. | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions |
DE102009022915A1 (de) * | 2009-05-27 | 2010-12-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit gesteuertem Wirkstofffluss |
CN102802418A (zh) * | 2009-06-19 | 2012-11-28 | 诺普神经科学股份有限公司 | 用于治疗肌萎缩性侧索硬化的组合物和方法 |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
EP3513787A1 (de) | 2011-01-10 | 2019-07-24 | Invion, Inc | Verwendung von beta-adrenergen inversen agonisten zur raucherentwöhnung |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
TW201338813A (zh) * | 2011-12-12 | 2013-10-01 | Lohmann Therapie Syst Lts | 經皮遞送系統 |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
US9074972B2 (en) | 2012-05-16 | 2015-07-07 | Dionex Corporation | Surrogate addition device and a method of analyte concentration |
CN103919754B (zh) * | 2013-01-15 | 2018-11-06 | 江苏康倍得药业股份有限公司 | 奥昔布宁药物组合物及其应用 |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
CA2902795C (en) | 2013-02-28 | 2021-06-15 | Dermira, Inc. | Glycopyrrolate salts |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
EP2999444A4 (de) | 2013-05-20 | 2016-10-12 | Mylan Inc | Erweiterte transdermale dosierung von pramipexol zur behandlung von neurologischen erkrankungen |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
CN105764507B (zh) | 2013-07-12 | 2019-07-19 | 诺普生物科学有限责任公司 | 治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平 |
ES2871556T3 (es) | 2013-08-13 | 2021-10-29 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de la urticaria crónica |
ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
US20150098997A1 (en) | 2013-10-07 | 2015-04-09 | Teikoku Pharma Usa, Inc. | Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions |
RU2648449C2 (ru) | 2013-10-07 | 2018-03-26 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина |
TWI645866B (zh) * | 2013-10-07 | 2019-01-01 | 美商帝國製藥美國股份有限公司 | 右美托咪啶經皮輸送裝置及使用其之方法 |
CN104666279A (zh) * | 2013-11-28 | 2015-06-03 | 上海现代药物制剂工程研究中心有限公司 | 载药的三维网状立体构型的透皮给药制剂及其制备方法 |
CA2973372A1 (en) | 2015-01-09 | 2016-07-14 | Chase Pharmaceuticals Corporation | Oxybutynin transdermal therapeutic system combination |
AU2016381351B2 (en) | 2015-12-30 | 2022-09-29 | Corium, Inc. | Systems and methods for long term transdermal administration |
US11541018B2 (en) | 2016-06-23 | 2023-01-03 | Corium, Llc | Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent |
CN109789113A (zh) | 2016-07-27 | 2019-05-21 | 考里安国际公司 | 美金刚透皮递送系统 |
JP7251033B2 (ja) | 2016-07-27 | 2023-04-04 | コリウム, エルエルシー | ドネペジル経皮送達システム |
CN111132669A (zh) * | 2017-07-26 | 2020-05-08 | 考里安公司 | 具有带溶剂填充孔的微孔膜的透皮递送系统 |
AU2018392686A1 (en) | 2017-12-20 | 2020-07-09 | Corium Pharma Solutions, Inc. | Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point |
WO2023069778A1 (en) * | 2021-10-22 | 2023-04-27 | Georgetown University | Non-invasive and passive transdermal drug delivery patch for parkinson's disease |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US4262003A (en) * | 1975-12-08 | 1981-04-14 | Alza Corporation | Method and therapeutic system for administering scopolamine transdermally |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4542013A (en) * | 1981-07-08 | 1985-09-17 | Key Pharmaceuticals, Inc. | Trinitroglycerol sustained release vehicles and preparation therefrom |
KR970009886B1 (ko) * | 1981-08-30 | 1997-06-19 | 히사미쯔세이야꾸 가부시기가이샤 | 소염진통 첩부제 |
GB8319096D0 (en) * | 1983-07-14 | 1983-08-17 | Harlands Of Hull Ltd | Topical dressings |
GB8509978D0 (en) * | 1985-04-18 | 1985-05-30 | Juhasz L | Wound dressings |
US4904475A (en) * | 1985-05-03 | 1990-02-27 | Alza Corporation | Transdermal delivery of drugs from an aqueous reservoir |
US4784857A (en) * | 1986-06-03 | 1988-11-15 | Smith And Nephew Associated Companies Plc | Drug delivery device, its preparation and use |
EP0319988A1 (de) * | 1987-12-09 | 1989-06-14 | Showa Denko Kabushiki Kaisha | Aüsserliche dermatologische Zubereitung |
US4915950A (en) * | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
US5217718A (en) * | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
US5298258A (en) * | 1989-12-28 | 1994-03-29 | Nitto Denko Corporation | Acrylic oily gel bioadhesive material and acrylic oily gel preparation |
US5314694A (en) * | 1990-10-29 | 1994-05-24 | Alza Corporation | Transdermal formulations, methods and devices |
US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
US5273756A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
US5234690A (en) * | 1991-08-23 | 1993-08-10 | Cygnus Therapeutic Systems | Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset |
US5225198A (en) * | 1991-08-27 | 1993-07-06 | Cygnus Therapeutic Systems | Transdermal administration of short or intermediate half-life benzodiazepines |
ES2137261T3 (es) * | 1992-05-13 | 1999-12-16 | Alza Corp | Administracion transdermica de oxibutinina. |
AU6410494A (en) * | 1993-03-17 | 1994-10-11 | Alza Corporation | Device for the transdermal administration of alprazolam |
CA2165802A1 (en) * | 1993-09-29 | 1995-04-06 | Eun Soo Lee | Monoglyceride/lactate ester permeation enhancer for oxybutynin |
-
1994
- 1994-09-29 US US08/315,043 patent/US5635203A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/481,544 patent/US5614211A/en not_active Expired - Lifetime
- 1995-09-15 DK DK95933122T patent/DK0783341T3/da active
- 1995-09-15 PT PT95933122T patent/PT783341E/pt unknown
- 1995-09-15 WO PCT/US1995/011732 patent/WO1996010429A2/en active IP Right Grant
- 1995-09-15 JP JP8511837A patent/JPH11501527A/ja active Pending
- 1995-09-15 AT AT95933122T patent/ATE209940T1/de not_active IP Right Cessation
- 1995-09-15 DE DE69524436T patent/DE69524436T2/de not_active Expired - Fee Related
- 1995-09-15 ES ES95933122T patent/ES2164780T3/es not_active Expired - Lifetime
- 1995-09-15 EP EP95933122A patent/EP0783341B1/de not_active Expired - Lifetime
-
2006
- 2006-03-01 JP JP2006054798A patent/JP2006143750A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE69524436D1 (de) | 2002-01-17 |
WO1996010429A3 (en) | 1996-07-25 |
US5635203A (en) | 1997-06-03 |
WO1996010429A2 (en) | 1996-04-11 |
US5614211A (en) | 1997-03-25 |
PT783341E (pt) | 2002-04-29 |
EP0783341B1 (de) | 2001-12-05 |
DE69524436T2 (de) | 2002-08-01 |
JP2006143750A (ja) | 2006-06-08 |
JPH11501527A (ja) | 1999-02-09 |
DK0783341T3 (da) | 2002-03-04 |
ES2164780T3 (es) | 2002-03-01 |
EP0783341A2 (de) | 1997-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE209940T1 (de) | Verbesserte transdermale vorrichtung mit verringerter delaminierung | |
DE69203990D1 (de) | Einrichtung zur transdermalen Verabreichung von Medikamenten. | |
FR2676913B1 (fr) | Dispositif d'ablation de matiere, notamment pour la dentisterie. | |
NL1000670A1 (nl) | dunne laag-ablatieapparaat. | |
DE3879853T2 (de) | Klebstoffzusammensetzung, Zusammensetzung mit kontrollierter Wirkstofffreisetzung und System zur transdermalen Anwendung von Arzneien. | |
ATE200028T1 (de) | Transdermale abgabe vorrichtung | |
DE69926686D1 (de) | Vorrichtung zur Verabreichung von hochkonzentrierten NO Pulsen | |
DK0973497T3 (da) | Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade | |
ATE253363T1 (de) | Nikotinhaltige verabreichungssysteme | |
ATE223244T1 (de) | Mehrschichtige durchfluss-kontrollierende membranen zur verwendung in einer elektrotransportvorrichtung | |
GR910100283A (el) | Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως. | |
TR199501613A2 (tr) | Ince filmler ve film/örülmemis laminatlar. | |
NO180518C (no) | Venekateterforbinding med vindu | |
DE69829961D1 (de) | Transdermale vorrichtung zur verabreichungvon von testosteron | |
FI942011A0 (fi) | Kiteytymisenestoaineita sisältäviä transdermaalisia terapeuttisia järjestelmiä | |
DE3875595D1 (de) | Bolusfoermige vorrichtung zur gesteuerten wirkstofffreisetzung. | |
DE69011097T2 (de) | Abreissbare, druckempfindliches medizinisches Klebeband mit kontinuierlichem Film. | |
DE3861977D1 (de) | Vorrichtung zur dosierbaren klebstoff-applikation. | |
DE68917710T2 (de) | Einrichtung zur Einstellung der Verstärkung. | |
ATE203906T1 (de) | Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol | |
DE69023504D1 (de) | Thermoplastische Klebschicht zur Halbleiterbefestigung. | |
ES1006978Y (es) | Dispositivo corrector nasal. | |
DE68921427D1 (de) | Vorrichtung zur Wiederherstellung des Gleichstroms. | |
FR2741579B1 (fr) | Dispositif a skis pour le transport de personnes, notamment de personnes handicapees | |
DE9402647U1 (de) | Fußball mit Zusatzeinrichtung zur Tonverstärkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |